TW0006949001
TW0006949001
PELL BIO-MED TECHNOLOGY CO LTD
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 61.42B EUR | 57.09B EUR | 36.4B EUR | 20.3B EUR |
Enterprise Value | 59.7B EUR | 55.47B EUR | 34.39B EUR | 20.23B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -- | -- | -- | -- |
Price to Sales | 2,123.21x | 2,669.57x | 1,988.25x | 849.84x |
Price to Book | 23.87x | 22.2x | 13.68x | 14.27x |
EV/Revenue | 2,063.92x | 2,593.78x | 1,878.49x | 846.93x |
EV/EBITDA | -129.06x | -- | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -0.71% | -0.86% | -1.14% | -1.75% |